1-20 of 26
Ana Marin-Niebla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, Massimo Mirandola, Karin E. Smedby, Maria Chiara Tisi, Eva Giné, Alexandra Albertsson-Lindblad, Ana Marin-Niebla, Alice Di Rocco, Filipa Moita, Roberta Sciarra, Sandra Bašić-Kinda, Georg Hess, Anke Ohler, Christian W. Eskelund, Alessandro Re, Isacco Ferrarini, Arne Kolstad, Riikka Räty, Francesca Maria Quaglia, Toby A. Eyre, Greta Scapinello, Piero Maria Stefani, Lucia Morello, Luca Nassi, Stefan Hohaus, Simone Ragaini, Vittorio Ruggero Zilioli, Riccardo Bruna, Federica Cocito, Annalisa Arcari, Mats Jerkeman, Carlo Visco
Journal: Blood
Blood (2024) 144 (9): 1001–1009.
https://doi.org/10.1182/blood.2023023525
Published: 2024
Includes: Supplemental data
Journal Articles

Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network

Vincent Ribrag, Violaine Safar, Hanneke Kluin-Nelemans, Lucie Oberic, Pierre Feugier, Olivier Casasnovas, Catherine Thieblemont, Nicolas Daguindau, Gandhi Laurent Damaj, Eva Hoster, Ludwig Fischer von Weikersthal, Mathias Hänel, Marc Andre, Maria Gomes Da Silva, Ana Marín Niebla, Michal Taszner, Jan Walewski, Rinske Boersma, Marie-Helene Delfau-Larue, Steven Le Gouill, Martin Dreyling
Journal: Blood
Blood (2023) 142 (Supplement 1): 979.
https://doi.org/10.1182/blood-2023-188788
Published: 2023
Journal Articles

Beyond MIPI: Harnessing Machine Learning and Histological Subtype for Enhanced MCL Prognostication of Survival

Adrian Mosquera Orgueira, Alba Carbita, Victor Navarro Garces, Pau Abrisqueta, Rodrigo Alonso Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 4419.
https://doi.org/10.1182/blood-2023-179174
Published: 2023
Journal Articles

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

Ana Marin Niebla, Mariana Bastos-Oreiro, Alba Cabirta Touzón, Marta Canelo Vilaseca, Juan-Manuel Sancho, Ana Jimenez Ubieto, Adolfo Jesús Sáez Marín, Ana Garcia Noblejas, Pablo Prieto Martinez, Concepcion Nicolas, Carlos Grande Garcia, Hugo Daniel Luzardo Henriquez, Jose Angel Hernandez Rivas, Ana Muntanola, Rosalia Alonso Trillo, Irene Arnaiz, Eva Donato, Paola Villafuerte Gutierrez, Daniel Garcia Belmonte, Alicia Roldan Perez, Sandra Suarez Ordonez, Víctor Navarro Garces, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2023) 142 (Supplement 1): 1678.
https://doi.org/10.1182/blood-2023-186101
Published: 2023
Journal Articles

A Novel Machine-Learning Model to Predict Early Relapse in Mantle Cell Lymphoma (MCL)

Alba Cabirta Touzón, Adrian Mosquera Orgueira, Victor Navarro Garces, Pau Abrisqueta, Rodrigo A Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz Vicente, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 1675.
https://doi.org/10.1182/blood-2023-181628
Published: 2023
Journal Articles

Novel Agents May be Preferable to Standard Chemotherapy in Second-Line for Early Relapsing Follicular Lymphoma (FL) Patients

Angel Serna, Marc Bosch, Víctor Navarro, Patricia Lopez-Pereira, David Quintela, Mireia Franch, Juan-Manuel Sancho, Adolfo Jesús Sáez Marín, Maria Poza, Ana Jimenez Ubieto, Alberto Lopez Garcia, Raul Cordoba, Maria Cerdá, Beatriz De La Cruz, Samuel Romero, Ainara Ferrero, Tomas Garcia Cerecedo, Cristina García Herce, Alba Cabirta Touzón, Ana Marin Niebla, Gloria Iacoboni, Francesc Bosch, Pau Abrisqueta Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 6168.
https://doi.org/10.1182/blood-2023-186019
Published: 2023
Journal Articles

Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)

Angel Serna, Angela Sanchez, Laia Lopez, Juan-Manuel Sancho, Eva Gonzalez Barca, Alberto Lopez-Garcia, Raul Cordoba, Adolfo Jesús Sáez Marín, Ana Isabel Jiminez Ubieto, Ainara Ferrero, Tomas García, Alba Cabirta, M Moraima Jimenez, Lucia Martin, Marta Julia, Sabela Bobillo, Ana Marin-Niebla, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2022) 140 (Supplement 1): 9350–9352.
https://doi.org/10.1182/blood-2022-165996
Published: 2022
Journal Articles

Rituximab Maintenance (RM) after First-Line (1L) Treatment Is Associated with a Lower Risk of Early-POD in Patients with Mantle Cell Lymphoma (MCL)

Alba Cabirta, Pau Abrisqueta, Víctor Navarro Garcés, Marta Canelo-Vilaseca, Marina Gomez-Rosa, Alberto Lopez García, Tomas García, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Moraima Jiménez, Sabela Bobillo, Marta Julia, Cecilia Carpio, Gloria Iacoboni, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin-Niebla
Journal: Blood
Blood (2022) 140 (Supplement 1): 9335–9337.
https://doi.org/10.1182/blood-2022-163180
Published: 2022
Journal Articles

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse

Clinical Trials & Observations
Chiara Rusconi, Chan Y. Cheah, Toby A. Eyre, David Tucker, Pavel Klener, Eva Giné, Lara Crucitti, Cristina Muzi, Sara Iadecola, Gabriele Infante, Sophie Bernard, Rebecca L. Auer, Chiara Pagani, Monika Duglosz-Danecka, Heidi Mocikova, Tom van Meerten, Emanuele Cencini, Ana Marin-Niebla, Michael E. Williams, Piera Angelillo, Paolo Nicoli, Annalisa Arcari, Lucia Morello, Donato Mannina, Orsola Vitagliano, Roberto Sartori, Annalisa Chiappella, Roberta Sciarra, Piero M. Stefani, Martin Dreyling, John F. Seymour, Carlo Visco
Journal: Blood
Blood (2022) 140 (17): 1907–1916.
https://doi.org/10.1182/blood.2022015560
Published: 2022
Includes: Supplemental data
Journal Articles

Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma

Thomas E. Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Dolores Caballero, Ranjana Advani, Raquel de Oña, Ana Marin Niebla, María José Terol, Domingo Domenech Eva, Nawal Bendris, Julie Mackey Ahsan, Mollie Leoni, Francine M. Foss
Journal: Blood
Blood (2021) 138 (Supplement 1): 621.
https://doi.org/10.1182/blood-2021-147279
Published: 2021
Journal Articles

Early Relapse after First Line Has a Significant Impact on Overall Survival in Patients with Mantle Cell Lymphoma (MCL)

Alba Cabirta, Pau Abrisqueta, Carla Sanchez-Ruiz, Sabela Bobillo, Cecilia Carpio, Gloria Iacoboni, Mercedes Gironella Mesa, Marta Julia, Angel Serna, Carlos Palacio, Josep Castellvi, Francesc Bosch, Ana Marin-Niebla
Journal: Blood
Blood (2021) 138 (Supplement 1): 1357.
https://doi.org/10.1182/blood-2021-150400
Published: 2021
Journal Articles

Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance after First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the MCL R2 Elderly Clinical Trial

Vincent Ribrag, Violaine Safar, Hanneke Kluin-Nelemans, Lucie Oberic, Pierre Feugier, Olivier Casasnovas, Catherine Thieblemont, Nicolas Daguindau, Gandhi Laurent Damaj, Wolfram Klapper, Eva Hoster, Ludwig Fischer von Weikersthal, Mathias Haenel, Marc André, Maria Gomes da Silva, Fernando Carcinero, Ana Marin-Niebla, Michal Taszner, Jan Walewski, Rinske Boersma, Ilse Houtenbos, Marie-Helene Delfau-Larue, Steven Le Gouill, Martin H. Dreyling
Journal: Blood
Blood (2021) 138 (Supplement 1): 379.
https://doi.org/10.1182/blood-2021-149600
Published: 2021
Journal Articles

Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Previously Treated with Ibrutinib (CITADEL-205)

Pier Luigi Zinzani, MD, Vincent Delwail, Shankara Paneesha, MD, Simon Rule, MD PhD, Alejandro Martin Garcia-Sancho, MD PhD, Ana Marin-Niebla, MD PhD, Gilles Salles, MD PhD, Juan-Manuel Sancho, MD PhD, Vibeke Vergote, MD, Vittorio Ruggero Zilioli, MD, Fred Zheng, MD, Douglas J DeMarini, PhD, Wei Jiang, PhD, Amitkumar Mehta, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-134609
Published: 2020
Journal Articles

Primary Analysis of the Tegar Study: A Phase II Study Exploring the Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab or Rituximab in Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), or Waldenstrom Macroglobulinemia (WM)

Panayiotis Panayiotidis, MD, Gayane Tumyan, Catherine Thieblemont, Vadim V Ptushkin, Ana Marin Niebla, Ramon Garcia-Sanz, Andrey Zaritskey, Steven Le Gouill, MD PhD, Christian Buske, MD, Marlies Van Hoef, Thomas Perretti, Monique S Tomiczek, Anastasios Stathis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-137087
Published: 2020
Journal Articles

Prognostic Impact of Metabolic Tumor Burden in Large B-Cell Lymphoma Patients Receiving CAR T-Cell Therapy

Gloria Iacoboni, MD, Marc Simo, MD, Guillermo Villacampa, Eva Catala, Cecilia Carpio, MD, Candido Diaz-Lagares, MD, Angela Vidal-Jordana, MD, Sabela Bobillo, MD, Ana Marin-Niebla, MD PhD, Ana Perez, MD, Moraima Jiménez, Pau Abrisqueta, MD PhD, David Valcárcel, MD PhD, Francesc Bosch, MD PhD, Pere Barba, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–29.
https://doi.org/10.1182/blood-2020-141777
Published: 2020
Journal Articles

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Eva Gine, MD, Maria de Fatima De La Cruz, MD, Carlos Grande, MD, Javier Lopez Jimenez, MD PhD, Alejandro Martín, MD PhD, Maria Jose Terol, Eva González-Barca, MD PhD, Adolfo de la Fuente, Ana Marin Niebla, PhD, Maria Casanova, MD, Ana Muntañola Prat, MD, Tomás José González-López, MD, Marta Aymerich, Lucia Palacios, MSC, Xavier Setoain, Montserrat Cortés-Romera, MD, Amanda Rotger, MD, Alejandro Medina, MD, Ramón García-Sanz, MD PhD, Elias Campo, Armando Lopez-Guillermo
Journal: Blood
Blood (2019) 134 (Supplement_1): 752.
https://doi.org/10.1182/blood-2019-122191
Published: 2019
Journal Articles

Proof of Concept for Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Thomas E. Witzig, MD, Lubomir Sokol, MD PhD, Francine M. Foss, MD, Won-Seog Kim, MD PhD, Eric Jacobsen, MD, Maria de Fatima De La Cruz, MD, Dolores Caballero, MD PhD, Ranjana H Advani, MD, Jose Maria Roncero, MD, Raquel de Oña, Ana Marin Niebla, PhD, Antonia Rodriguez Izquierdo, Maria Jose Terol, Eva Domingo-Domenech, MD, Miguel A. Piris, Marta Rodriguez, James Bolognese, PhD, Linda Kessler, BA, Vishnu Mishra, PhD, Robert Curry, BA, MBA, Michael Kurman, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 468.
https://doi.org/10.1182/blood-2019-128513
Published: 2019
Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Juan-Manuel Sancho, MD PhD, Olga García, Pablo Mozas, Santiago Mercadal, MD, Eva Donato, MD, Ana Muntañola Prat, MD, Javier Lopez Jimenez, MD, Pascual Fernandez Abellan, PhD, Jose-Angel Hernandez, MD, Maria J. Rodriguez-Salazar, MD, Samuel Romero, MD, Ana Marin Niebla, PhD, Angel Ramirez Payer, Raul Cordoba, MD PhD, Jose Luis Bello, MD, Beatriz Cuevas, MD, Itziar Oiartzabal, MD, Alejandro Martín, MD PhD, Jose Javier Sanchez Blanco, Nicholas Kelleher, MD, Ana Lafuente, MD, Marc Sorigué, MD, López Guillermo Armando, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5249.
https://doi.org/10.1182/blood-2019-125921
Published: 2019
Journal Articles

Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Thomas E. Witzig, MD, Lubomir Sokol, MD PhD, Eric D Jacobsen, MD, Won-Seog Kim, MD PhD, Francine M. Foss, MD, Ranjana H. Advani, MD, Jose Maria Roncero Vidal, MD, Ana Marin Niebla, PhD, Antonia Rodriguez Izquierdo, PhD, Raquel De Ona Navarrete, MD, Fátima de la Cruz Vicente, MD, Dolores Caballero, MD, Rufino Mondejar, PhD, Miguel A. Piris, PhD MD, Robert Curry, BA, MBA, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2937.
https://doi.org/10.1182/blood-2018-99-116277
Published: 2018
Journal Articles

Extranodal Natural Killer/T-Cell Lymphoma Nasal Type in 87 Cases from Spain: Clinical Presentation, Treatment and Prognostic Factors. Study from the Geltamo Group

Eva González-Barca, MD PhD, Alejandro Martín, MD, Jose Luis Bello, Juan Miguel Miguel Bergua Burgues, Carlos Panizo, MDPhD, Maite Encuentra, Ana Monter Rovira, Raul Cordoba, MD PhD, Mariana Bastos, MD, Jose Javier Sanchez Blanco, Pilar Gomez, Ana Marin Niebla, PhD, Sonia González de Villambrosia, MD, Maria Jose Sayas, Hugo Daniel Luzardo Henriquez, MD, Maria De La Cruz Viguria Alegria, Blanca Sanchez-Gonzalez, MD PhD, Monica Roig, Jaime Perez De Oteyza, MDPhD, Elena Cabezudo, Lourdes Escoda, MD, Raquel de Oña, Josë Antonio Queizan, Maria Stefania Infante, Ana Muntañola Prat, Andres Lopez
Journal: Blood
Blood (2018) 132 (Supplement 1): 1637.
https://doi.org/10.1182/blood-2018-99-110792
Published: 2018